Jorge Morales

Jorge Morales serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and diagnostic capabilities. He manages a portfolio of contracts focused on laboratory diagnostics, infectious disease detection systems, and data-driven public health infrastructure, ensuring timely access to technologies that enable rapid response to emerging health threats. His work directly supports CDC’s operational readiness by facilitating the procurement of high-compliance, high-accuracy medical devices and analytical platforms essential for national surveillance and outbreak response. Morales maintains longstanding partnerships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, Inc., GlaxoSmithKline, LLC, MRIGLOBAL, Cepheid, and the New York City Health & Hospitals Corp. These relationships are characterized by consistent, high-volume contracting for specialized services such as molecular diagnostics, biosurveillance systems, and clinical laboratory support. His approach emphasizes performance-based outcomes, technical compliance with federal health standards, and long-term vendor collaboration to ensure continuity in mission-critical operations. Morales’s contracting activity is exclusively non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and operational scalability over socioeconomic preferences, prioritizing the most qualified vendors capable of meeting CDC’s stringent scientific and regulatory requirements. While small business participation is not formally incentivized in his portfolio, all awards adhere to federal acquisition regulations and competitive fairness standards. His primary focus lies in NAICS 621999, encompassing all other miscellaneous ambulatory health care services, particularly those involving advanced diagnostic testing, point-of-care technologies, and integrated public health data systems. He specializes in procuring complex, high-sensitivity laboratory equipment and associated analytical services that support CDC’s frontline response to infectious disease outbreaks and bioterrorism threats.